Pathologic features and clinical outcome of central neurocytoma: analysis of 15 cases.
OBJECTIVE
To get better recognition of central neurocytoma and diminish misdiagnosis.


METHODS
A retrospective review identified 15 cases of central neurocytoma. All cases of central neurocytoma were analyzed for their clinical symptoms, pathologic changes, immunohistochemical staining, prognosis and differential diagnosis. Clinical follow up was performed.


RESULTS
There were 8 males and 7 females aged 10-64 years (median 32.93 years). The most common presenting symptoms were those related to increased intracranial pressure (ICP), including headache (100%), papilledema (93%) and vomiting (80%). All tumors were located in the ventricular system. The tumors were composed of uniform cells with round nuclei and a fine chromatin pattern, and in some areas, small cells with perinuclear halo could be seen. In particular, the anuclear areas may have a fine fibrillary matrix (neuropil). Nuclear atypia and vascular proliferation appeared in two cases, respectively. Focal necrosis could be seen in one case. Immunohistochemical findings included expression of synaptophysin (15/15), neuron specific enolase (12/15) and glial fibrillary acidic protein (GFAP) (3/15). MIB-1 proliferation index ranged from 0.8-12.5%, and was more than 2% in 3 of 15 cases assessed. Follow-up information of 11 patients was available.


CONCLUSIONS
Central neurocytoma has a favorable prognosis in general, but in some cases, the clinical course could be aggressive. Increase of GFAP positivity, proliferation index and vascular proliferation might suggest a more malignant process.
Institute of Neuroscience, Department of Pathology, Chongqing Medical University, Chongqing 400016, China.
Yu
Y
Li
Xiu-Feng
XF
Ye
Guo
G
Qian
Yu
Y
Yin
Qian-Guan
QG
Pan
Central neurocytoma; MIB-1 labeling index; histopathology; immunohistochemistry; proliferation